Thalidomide in multiple myeloma: state of art

Haematologica. 2002 Mar;87(3):233-4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Salvage Therapy
  • Thalidomide / adverse effects
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Thalidomide